Esperion Theraptc
(ESPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189,304 | 226,609 | 82,248 | 114,833 | 138,470 |
| Receivables | 60,360 | 54,612 | 48,494 | 42,623 | 40,799 |
| Inventories | 84,469 | 73,095 | 65,623 | 51,435 | 45,676 |
| Other current assets | 10,626 | 11,290 | 4,507 | 6,287 | 4,317 |
| TOTAL | $345,108 | $365,606 | $201,065 | $218,227 | $232,125 |
| Non-Current Assets | |||||
| PPE Net | 307 | 268 | N/A | 6 | 32 |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 6,848 | 7,130 | 4,675 | 3,016 | 2,413 |
| TOTAL | $7,211 | $7,454 | $4,731 | $3,078 | $2,501 |
| Total Assets | $352,319 | $373,060 | $205,796 | $221,305 | $234,626 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 47,669 | 28,433 | 31,718 | 26,214 | 24,558 |
| Accrued Expenses | 48,270 | 37,564 | 37,725 | 34,556 | 30,659 |
| Other current liabilities | 32,754 | 43,486 | 34,828 | 37,013 | 22,784 |
| TOTAL | $175,338 | $164,512 | $156,224 | $137,708 | $107,173 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 20,672 | 29,350 | 25,402 | 19,723 | 15,634 |
| Other Non-Current Liabilities | 521,201 | 502,846 | 504,566 | 493,601 | 499,431 |
| TOTAL | $521,201 | $502,846 | $504,566 | $493,601 | $499,431 |
| Total Liabilities | $696,539 | $667,358 | $660,790 | $631,309 | $606,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 196,225 | 189,460 | 185,053 | 113,718 | 106,994 |
| Common Shares | 195 | 188 | 118 | 112 | 101 |
| Retained earnings | -1,550,187 | -1,488,262 | -1,549,284 | -1,492,940 | -1,451,690 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $-344,220 | $-294,298 | $-454,994 | $-410,004 | $-371,978 |
| Total Liabilities And Equity | $352,319 | $373,060 | $205,796 | $221,305 | $234,626 |